Extracellular enzymes and βeta-lactamase screening of bacterial isolates cultured from urine samples of immunocompromised women

O. V. Olagoke; B. I. Alao; J. O. Jimoh; T. O. Ladipo

doi:10.30574/gscbps.2018.4.3.0043

Authors

O. V. Olagoke Department of Microbiology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
B. I. Alao Department of Agricultural Development Management, Agricultural and Rural Management Training Institute (ARMTI), Ilorin, Nigeria.
J. O. Jimoh Department of Agricultural Development Management, Agricultural and Rural Management Training Institute (ARMTI), Ilorin, Nigeria.
T. O. Ladipo Department of Agricultural Development Management, Agricultural and Rural Management Training Institute (ARMTI), Ilorin, Nigeria.

DOI:

https://doi.org/10.30574/gscbps.2018.4.3.0043

Keywords:

Screening, Extracellular enzymes, Bacteria, HIV seropositive

Abstract

Enzymes intricate by organisms are used to inactivate and destroy antibiotics. This study determined some virulence factors elaborated by the bacterial isolates cultured from urine samples of HIV seropositive pregnant women that attended antenatal clinic of the Ondo State Specialist Hospital, Akure. Screening for extracellular enzymes and extended spectrum beta lactamase (ESBL) of the isolate was carried out using standard method and disk approximation method respectively. The extracellular enzymes such as lipase, protease and DNase were detected in the three bacterial genera used. ESBL was found in S. aureus and E. coli. The study concluded that most of the bacterial isolates cultured from urine samples of HIV seropositive pregnant women in the study area were found to have these virulence factors.

Metrics

Metrics Loading ...

References

Bush K and Jacoby GA. (2010). Updated functional classification of β-lactamases. Antimicrobial Agents Chemotherapy, 54, 969-76.

Bradford PA. (2001). Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews, 14, 933-51.

Pfaller MA and Segreti J. (2006). Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clinical Infectious Disease, 42(4), S153-63.

Livermore DM. (2003). Bacterial resistance: origins, epidemiology, and impact. Clinical Infectious Disease, 36(1), S11-23.

Lim YK, Lee MK and Kim TH. (2015). (2015). Management of extended-spectrum beta-lactamase-positive gram-negative bacterial urologic infections. Urogenital Tract Infection, 10(2), 84-91.

Rupp ME and Fey PD. (2003). Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs, 63, 353-65.

Bell JM, Turnidge JD and Gales AC. (2002). Prevalence of extended spectrum β-lactamase (ESBL) producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiology Infectious Disease, 42, 193-8.

Bush K. (2001). New β-lactamases in Gram-negative bacteria: Diversity and impact on the selection of antimicrobial therapy. Clinical Infectious Disease, 32, 1085-9.

Livermore DM. (1995). β-lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews, 8, 557-84.

Oplustil CP, Nunes R and, Mendes C. (2001). Multicenter evaluation of resistance patterns of Klebsiella pneumoniae, E. coli, Salmonella sp. and Shigella sp. isolated from clinical specimens in Brazil: Resisant Surveillance Program. Brazil Journal of Infectious Disease, 5, 8-12.

Olagoke OV, Oyewale OO, Olufehinti MO and Adesina BS, (2018). Plasmid Profile of Bacteria. International Journal of Current Microbiology and Applied Science, 7(06), 2319-7706

Smibert RM, and Krieg NR. (1981). General characterization. In Manual of Methods for General Bacteriology, Edited by P. Gerhardt and others. Washington, DC: American Society for Microbiology, 409-443.

Thomson KS and Sanders CC. (1992). Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional test. Antimicrobial Agents Chemotherapy, 36(11), 1877-1882.

Tumane PM and Durgesh DW. (2013). Occurrence of extended spectrum beta-lactamase producing Enterobacteriaceae causing wound infections. Asian Journal of Biomedical and Pharmaceutical Sciences, 3(20), 55-58.